P10721 KIT_HUMAN
Gene name: KIT
Protein name: Mast/stem cell growth factor receptor Kit
List of molecules and drugs that target protein P10721
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P10721_DB00398 | DB00398 | Sorafenib | antagonist | Ki(nM) = 16000.0 IC50(nM) = 31.0 Kd(nM) = 16.0 | MLDQJTXFUGDVEO-UHFFFAOYSA-N | CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1 |
2 | P10721_DB00619 | DB00619 | Imatinib | antagonist | Ki(nM) = 14.0 IC50(nM) = 16.0 Kd(nM) = 3.0 EC50(nM) = 100.0 | KTUFNOKKBVMGRW-UHFFFAOYSA-N | CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1 |
3 | P10721_DB01254 | DB01254 | Dasatinib | antagonist | Ki(nM) = 620.0 IC50(nM) = 1.0 Kd(nM) = 0.4 | ZBNZXTGUTAYRHI-UHFFFAOYSA-N | CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1 |
4 | P10721_DB01268 | DB01268 | Sunitinib | inhibitor | Ki(nM) = 4.0 IC50(nM) = 1.1 Kd(nM) = 0.21 | WINHZLLDWRZWRT-ATVHPVEESA-N | CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C |
5 | P10721_DB01962 | DB01962 | Phosphonotyrosine | n/a | DCWXELXMIBXGTH-QMMMGPOBSA-N | N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O | |
6 | P10721_DB04868 | DB04868 | Nilotinib | antagonist | Ki(nM) = 2.0 IC50(nM) = 15.0 Kd(nM) = 17.0 | HHZIURLSWUIHRB-UHFFFAOYSA-N | CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F |
7 | P10721_DB05913 | DB05913 | OSI-930 | n/a | FGTCROZDHDSNIO-UHFFFAOYSA-N | FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=CC=CC=C34)C=CS2)C=C1 | |
8 | P10721_DB06080 | DB06080 | Linifanib | n/a | MPVGZUGXCQEXTM-UHFFFAOYSA-N | CC1=CC(NC(=O)NC2=CC=C(C=C2)C2=C3C(N)=NNC3=CC=C2)=C(F)C=C1 | |
9 | P10721_DB06589 | DB06589 | Pazopanib | inhibitor | Ki(nM) = 2300.0 IC50(nM) = 118.0 Kd(nM) = 1.8 | CUIHSIWYWATEQL-UHFFFAOYSA-N | CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1 |
10 | P10721_DB06595 | DB06595 | Midostaurin | antagonist | BMGQWWVMWDBQGC-IIFHNQTCSA-N | CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1 | |
11 | P10721_DB08896 | DB08896 | Regorafenib | inhibitor | IC50(nM) = 6.1 | FNHKPVJBJVTLMP-UHFFFAOYSA-N | CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1 |
12 | P10721_DB08901 | DB08901 | Ponatinib | inhibitor | IC50(nM) = 1.7 | PHXJVRSECIGDHY-UHFFFAOYSA-N | CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1 |
13 | P10721_DB09078 | DB09078 | Lenvatinib | inhibitor | WOSKHXYHFSIKNG-UHFFFAOYSA-N | COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O | |
14 | P10721_DB11800 | DB11800 | Tivozanib | inhibitor | SPMVMDHWKHCIDT-UHFFFAOYSA-N | COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1 | |
15 | P10721_DB12010 | DB12010 | Fostamatinib | inhibitor | GKDRMWXFWHEQQT-UHFFFAOYSA-N | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC | |
16 | P10721_DB12147 | DB12147 | Erdafitinib | substrate | OLAHOMJCDNXHFI-UHFFFAOYSA-N | COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1 | |
17 | P10721_DB12742 | DB12742 | Amuvatinib | n/a | FOFDIMHVKGYHRU-UHFFFAOYSA-N | S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1 | |
18 | P10721_DB12978 | DB12978 | Pexidartinib | inhibitor | JGWRKYUXBBNENE-UHFFFAOYSA-N | FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1 | |
19 | P10721_DB14840 | DB14840 | Ripretinib | inhibitor | CEFJVGZHQAGLHS-UHFFFAOYSA-N | CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1 | |
20 | P10721_DB15233 | DB15233 | Avapritinib | inhibitor | DWYRIWUZIJHQKQ-SANMLTNESA-N | CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1 |